Altamira Therapeutics Ltd. (CYTOF) vs Silexion Therapeutics Corp (SLXN)

Altamira Therapeutics Ltd. and Silexion Therapeutics Corp are both Biotechnology companies. Silexion Therapeutics Corp is the larger, with a market value of $1.4M against $1.1M — 1.3× the size. Across the 9 metrics below, Silexion Therapeutics Corp leads on 5 and Altamira Therapeutics Ltd. on 4.

Valuation

Metric CYTOF SLXN Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 0.07 4.06 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.04 0.74
EV/Sales n/m n/m 10.73
Earnings yield (57,271.43%) (8,359.54%) (28.84%)
Free cash flow yield (8,408.06%) (6,963.95%) (23.03%)

Profitability

Metric CYTOF SLXN Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (17,021.95%) (57.72%)
Return on assets 0.00% (277.96%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CYTOF SLXN Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 65.95% 97.73% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CYTOF SLXN Biotechnology median
Debt to equity 0.11 0.00 0.00
Current ratio 0.11 0.94 4.73
Net debt to EBITDA 0.15 0.38 0.96

Dividend

Metric CYTOF SLXN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CYTOF SLXN Biotechnology median
Market cap 1.13m 1.44m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack